More news about Trofinetide

By Rachael Bloom

Neuren have announced today (March 2nd 2015)  that their FDA application for Breakthrough Therapy status for Trofinetide to treat the symptoms of Rett Syndrome has been denied.

The announcement states: 'Breakthrough Therapy will...

RSRT Awards $7.2 million to research

This past summer saw a number of high profile papers published by RSRT/Reverse Rett funded scientists.


One of these papers was a study from Gail Mandel’s lab showing for the first time, the reversal of many Rett symptoms in adult female mice...

Page 4 of 5 pages